Journal of Mucosal Immunology Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Mucosal Immunol Res.,
  • DOI: 10.4172/jmir.1000150

Parathyroid Carcinoma on the Basis of Isolated Familial Hyperparathyroidism

Dr Semiha Calkaya* and Dr Fahri Bayram
Department of Rheumatology/Immunology, Istanbul Technical University, Turkey
*Corresponding Author : Dr Semiha Calkaya, Department of Rheumatology/Immunology, Istanbul Technical University, Turkey, Email: semihacalkaya@hotmail.com

Received Date: Aug 02, 2022 / Published Date: Aug 31, 2022

Abstract

Parathyroid carcinoma is a very rare endocrine neoplasm which results high production of parathyroid hormone (PTH) responsible for pathologic high calcium levels resulting in bone pain/fractures, renal disease and other signs of hypercalcemia. Clinically the disease is detected in patients earlier important because the morbidity and mortality are significant and the best prognosis is associated with early diagnosis and surgical resection.

Here, we present a rare case of familial hyperparathyroidism in which he and his two sons were diagnosed. We report a case of a 59 year old male who presented to our hospital with persistent hyperparathyroidism and hypercalcemia 6 years after having undergone total of two parathyroidectomy operations in this hospital and another.

Development of parathyroid carcınoma in isolated familial primary hyperparathyroidism should be kept in mind. The primary treatment of parathyroid carcinoma on the basis of isolated familial hyperparathyroidism is surgery. When the tumor is no longer amenable to surgical intervention, treatment becomes focused on the control of hypercalcemia with medical therapy, which can include bisphosphonates, calcimimetic agents, or denosumab.

Citation: Semiha Calkaya, Fahri Bayram, Figen Ozturk, Alperen Vural (2022) Parathyroid Carcinoma on the Basis of Isolated Familial Hyperparathyroidism. J Mucosal Immunol Res.6:150 Doi: 10.4172/jmir.1000150

Copyright: © 2022 Semiha C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top